Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-06-12

Clinical Trial Update: Effect of Omega-3 Fatty Acid Supplementation on Hypertriglyceridemia in HIV-infected Children [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating omega-3 fatty acid supplementation for hypertriglyceridemia in HIV-infected children; the study was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: The Hospital for Sick Children | Conditions: Hypertriglyceridemia | Phase 2 | Status: TERMINATED